相关实验视频
Updated: Jun 15, 2025

10:15
Isolation and Culture Expansion of Tumor-specific Endothelial Cells
Published on: October 14, 2015
11.2K
结直肠癌中的内皮细胞异质性:尖端细胞驱动血管生成
Zhenyu Xie1, Liaoran Niu1, Kunli Du1
1Department of Digestive Surgery, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, 169 Changle Road, Xi'an, Shaanxi, 710032, China.
Cellular and molecular life sciences : CMLS
|August 22, 2024
概括
结肠直肠癌内皮细胞 (ECs) 显示血管新生增加,由尖端细胞驱动. 准尖端细胞可能会改善结直肠癌免疫疗法.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 免疫学 免疫学 免疫学
背景情况:
- 内皮细胞 (ECs) 在瘤血管生成中发挥着关键作用.
- 在EC群体内的异质性影响瘤进展和治疗反应.
- 尖端细胞是血管生成的关键调节者.
研究的目的:
- 研究结直肠癌 (CRC) 中内皮细胞 (EC) 的异质性.
- 阐明尖端细胞在CRC血管生成和进展中的作用.
- 在CRC EC中识别潜在的治疗点.
主要方法:
- 单细胞RNA测序 (scRNA-seq) 用于分析CRC中的EC.
- 对尖端细胞密度和比例与CRC特征的分析.
- 研究分子通路,包括VEGFA-KDR-ESM1反循环.
- 评估PD-1阻断免疫治疗对尖端细胞的影响.
主要成果:
- CRC ECs表现出增强的血管生成和降低的抗原呈现,由尖端细胞控制.
- 尖端细胞密度增加与CRC发生,进展和预后不佳相关.
- 尖端细胞中的内皮细胞特异性分子1 (ESM1) 维持了一个亲血管性VEGFA-KDR-ESM1反循环.
- 阻断PD-1免疫疗法减少了尖端细胞,并破坏了VEGFA-KDR-ESM1循环.
结论:
- CRC EC异质性,特别是尖端细胞,驱动瘤血管生成和进展.
- 尖端细胞中的VEGFA-KDR-ESM1轴是关键的亲瘤源途径.
- 准尖端细胞对于开发新的结直肠癌免疫疗法具有前景.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Mechanism of Angiogenesis
5.4K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.4K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K

